Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
62 hedge funds and large institutions have $224M invested in Oxford Immunotec Global PLC Ordinary Shares in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 9 reducing their positions, and 6 closing their positions.
211% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 9
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
41% more capital invested
Capital invested by funds: $158M → $224M (+$65.2M)
11% more funds holding
Funds holding: 56 → 62 (+6)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
+$2.63M |
| 2 |
RI
RTW Investments
New York
|
+$2.37M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
+$1.53M |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$1.3M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
-$6.6M |
| 2 |
First Manhattan
New York
|
-$3.17M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$456K |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$282K |
| 5 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$179K |
OXFD Hedge Fund Activity: Q3 2016 in Review
62 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q3 2016, worth a combined $224M — up 41% from $158M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new OXFD positions and 6 closed out — a net gain of 7 holders — while 28 added to existing stakes and 9 trimmed.
The largest buyer was Tiverton Asset Management, opening a new position worth an estimated $2.63M. The largest seller was OppenheimerFunds, exiting entirely with an estimated $6.6M sold.
- 62 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q3 2016, up from 56 in Q2 2016.
- Funds reported $224M of Oxford Immunotec Global PLC Ordinary Shares stock for Q3 2016, up 41% quarter-over-quarter.
- 13 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q3 2016 and 6 closed out, a net change of +7 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q3 2016 was Tiverton Asset Management, an estimated $2.63M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q3 2016 was OppenheimerFunds, an estimated $6.6M sold.
Based on aggregated 13F filings for Q3 2016.